Internal Medicine, Rheumatology · Port Richey, FL
NPI
1346292414
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
8029 Washington St
Port Richey, FL, 34668
Phone (352) 596-4080
Groups this clinician bills Medicare through
Medicare paid, 2024
$956K
50,667 services
Medicare patients, 2024
475
Average age 74
Drug cost, 2024
$6.7M
5,582 prescriptions
Company payments, 2025
$278
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farrukh Zaidi was code J0129 (injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 14,925 times for 24 patients. In total Farrukh Zaidi billed 50,667 services in 33 codes, and Medicare paid $956K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 14,925 | 24 | $33.85 | $505K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 6,250 | 12 | $9.10 | $57K |
| J0897 Injection, denosumab, 1 mg | Office | 3,900 | 52 | $20.57 | $80K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,740 | 49 | $0.10 | $378 |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,360 | 11 | $24.67 | $58K |
| 99214 Office E&M - Established | Office | 715 | 322 | $87.73 | $63K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 480 | 263 | $12.62 | $6,059 |
| 96413 Chemotherapy Administration | Office | 331 | 52 | $96.35 | $32K |
| 96415 Chemotherapy Administration | Office | 128 | 13 | $20.87 | $2,671 |
| 96401 Chemotherapy Administration | Office | 117 | 14 | $53.31 | $6,237 |
| 99204 Office E&M - New | Office | 115 | 115 | $115.52 | $13K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 95 | 19 | $4.52 | $430 |
| 96372 Injection Administration | Office | 94 | 74 | $10.46 | $983 |
| 99213 Office E&M - Established | Office | 93 | 81 | $57.94 | $5,388 |
| 20611 Joint Injection | Office | 32 | 27 | $74.61 | $2,388 |
By year: 2022 $938K for 43,068 services; 2023 $845K for 46,639 services; 2024 $956K for 50,667 services.
Medicare prescription drug claims, 2024
In 2024, the drug Farrukh Zaidi prescribed most often to Medicare patients was Prednisone, with 1,105 prescriptions and refills. In total Farrukh Zaidi wrote 5,582 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,105 | 1,667 | 315 | $9,399 |
| Methotrexate Methotrexate Sodium | 872 | 1,715 | 214 | $15K |
| Hydroxychloroquine Sulfate Generic | 515 | 1,193 | 153 | $14K |
| Folic Acid Generic | 203 | 434 | 59 | $1,046 |
| Gabapentin Generic | 200 | 297 | 55 | $2,449 |
| Meloxicam Generic | 184 | 310 | 62 | $621 |
| Humira(Cf) Pen Adalimumab | 167 | 167 | 20 | $1.3M |
| Tramadol Hcl Generic | 124 | 124 | 27 | $1,416 |
| Celecoxib Generic | 110 | 215 | 38 | $6,936 |
| Rinvoq Upadacitinib | 107 | 121 | 14 | $766K |
| Pregabalin Generic | 106 | 137 | 18 | $4,967 |
| Allopurinol Generic | 96 | 236 | 29 | $954 |
| Duloxetine Hcl Generic | 91 | 215 | 29 | $2,724 |
| Diclofenac Sodium Generic | 80 | 125 | 27 | $1,401 |
| Methylprednisolone Generic | 78 | 100 | 28 | $2,214 |
Brand drugs: - claims; generic drugs: 4,550 claims; opioid claims: 233.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farrukh Zaidi $278 ($278 in general payments such as food, travel and fees) from 8 companies. The largest payer was UCB, Inc. with $162.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.